Thomas Hedner,
#124,485
Most Influential Person Now
Thomas Hedner,'s AcademicInfluence.com Rankings
Thomas Hedner,philosophy Degrees
Philosophy
#5780
World Rank
#8678
Historical Rank
Logic
#2997
World Rank
#4088
Historical Rank
Download Badge
Philosophy
Why Is Thomas Hedner, Influential?
(Suggest an Edit or Addition)Thomas Hedner,'s Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial (1999) (2032)
- Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study (1999) (1470)
- Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans (2008) (1392)
- Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study (2000) (950)
- Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point. (1992) (487)
- Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? (1988) (388)
- The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. (1997) (356)
- Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension. (1998) (302)
- Genome-Wide Association Study of Blood Pressure Extremes Identifies Variant near UMOD Associated with Hypertension (2010) (285)
- Common Missense Variant in the Glucokinase Regulatory Protein Gene Is Associated With Increased Plasma Triglyceride and C-Reactive Protein but Lower Fasting Glucose Concentrations (2008) (272)
- Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P (1994) (238)
- Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project. (2001) (226)
- Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: results from the Swedish Trial in Old Patients with Hypertension–2 (2000) (222)
- Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat (1992) (211)
- Survival in treated hypertension: follow up study after two decades (1998) (207)
- Brain natriuretic peptide predicts mortality in the elderly. (1997) (197)
- Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose (2008) (185)
- Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide. (1991) (183)
- Baroreflex modulation of sympathetic activity and sympathetic neurotransmitters in humans. (1988) (182)
- Blood pressure loci identified with a gene-centric array. (2011) (177)
- Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia (1998) (166)
- H35: Baseline characteristics of the life (Losartan intervention for endpoint reduction) in hypertension study (1997) (161)
- Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study. (2009) (157)
- The neuropharmacology of respiratory control. (1982) (151)
- Pharmacokinetic Aspects of Intrathecal Morphine Analgesia (1984) (148)
- Mutations of CASK cause an X-linked brain malformation phenotype with microcephaly and hypoplasia of the brainstem and cerebellum (2008) (138)
- Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors. (1992) (135)
- Localization of pain in suspected acute myocardial infarction in relation to final diagnosis, age and sex, and site and type of infarction. (1996) (133)
- COX-2-Specific Inhibitors – the Emergence of a New Class of Analgesic and Anti-inflammatory Drugs (2000) (127)
- Stroke is More Common than Myocardial Infarction in Hypertension: Analysis based on 11 Major Randomized Intervention Trials (2001) (125)
- Pharmacokinetic Aspects of Epidural Morphine Analgesia (1983) (123)
- The CSF and plasma pharmacokinetics of sufentanil after intrathecal administration. (1991) (123)
- Functional autoimmune epitope on α1-adrenergic receptors in patients with malignant hypertension (1994) (119)
- Ambulatory blood pressure 16‐26 years after the first urinary tract infection in childhood (2000) (117)
- Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure. (1991) (110)
- Relation between drug treatment and cancer In hypertenslves in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial (2001) (106)
- Plasma Lipid Composition and Risk of Developing Cardiovascular Disease (2013) (104)
- Pharmacokinetics and tolerability of different doses of fentanyl following sublingual administration of a rapidly dissolving tablet to cancer patients: a new approach to treatment of incident pain. (2005) (103)
- A common polymorphism in the interleukin-6 gene promoter is associated with overweight (2004) (101)
- Regional haemodynamic effects of endothelin-1 in rat and man: unexpected adverse reaction. (1990) (101)
- Development of diabetes is retarded by ACE inhibition in hypertensive patients – a subanalysis of the Captopril Prevention Project (CAPPP) (2004) (100)
- Smoking affects blood pressure. (1996) (100)
- A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension. (1999) (99)
- Genomic Association Analysis of Common Variants Influencing Antihypertensive Response to Hydrochlorothiazide (2013) (97)
- Myocardial Turnover of Endogenous Opioids and Calcitonin-Gene-Related Peptide in the Human Heart and the Effects of Spinal Cord Stimulation on Pacing-Induced Angina Pectoris (1998) (96)
- Topical Anesthesia with Lidocaine Aerosol in the Control of Postoperative Pain (1988) (95)
- Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure. (1998) (95)
- STOP-Hypertension 2: a prospective intervention trial of "newer" versus "older" treatment alternatives in old patients with hypertension. Swedish Trial in Old Patients with Hypertension. (1993) (92)
- Growth hormone improves cardiac function in rats with experimental myocardial infarction (1997) (86)
- Diabetes mellitus in treated hypertension: incidence, predictive factors and the impact of non-selective beta-blockers and thiazide diuretics during 15 years treatment of middle-aged hypertensive men in the Primary Prevention Trial Göteborg, Sweden. (1994) (85)
- A functional variant of the NEDD4L gene is associated with beneficial treatment response with β-blockers and diuretics in hypertensive patients (2011) (78)
- Autoantibodies against cardiac G-protein-coupled receptors define different populations with cardiomyopathies but not with hypertension. (1994) (77)
- Hypertension optimal treatment (HOT) study: home blood pressure in treated hypertensive subjects. (1998) (77)
- Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF-dilatation in congestive heart failure. (1999) (74)
- Selected CSF biochemistry and gabapentin concentrations in the CSF and plasma in patients with partial seizures after a single oral dose of gabapentin (1992) (74)
- Brain natriuretic peptide in an elderly population (1997) (72)
- Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors (1994) (71)
- Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration (1995) (70)
- Effects of Lidocaine Infusion on the Sympathetic Response to Abdominal Surgery (1987) (69)
- Is smoking a causative factor of hypertension? (2005) (69)
- The early clinical history of salicylates in rheumatology and pain (2005) (68)
- Local effects of substance P on respiratory regulation in the rat medulla oblongata. (1990) (68)
- Regulation of breathing in the rat: Indications for a role of central adenosine mechanisms (1982) (67)
- Inhibition of 17 beta-estradiol metabolism by grapefruit juice in ovariectomized women. (1994) (66)
- Effects of TRH and TRH analogues on the central regulation of breathing in the rat. (1983) (65)
- Effects of atrial natriuretic peptide on acute renal impairment in patients with heart failure after cardiac surgery (1994) (64)
- Circulatory effects of noise. (2009) (64)
- Increase in cardiac P2X1-and P2Y2-receptor mRNA levels in congestive heart failure. (1999) (64)
- Ketanserin, a novel 5-hydroxytryptamine antagonist: monotherapy in essential hypertension. (1983) (63)
- Adenosine mechanisms in the regulation of breathing in the rat. (1984) (62)
- A population study of the pharmacokinetics of felodipine. (1991) (62)
- Interaction Between Renal Function and Microalbuminuria for Cardiovascular Risk in Hypertension: The Nordic Diltiazem Study (2008) (62)
- Calcium channel blockers: spectrum of side effects and drug interactions. (2009) (62)
- The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of coronary events in patients with hypertension (2009) (60)
- Pain characterization in cancer patients and the analgetic response to epidural morphine (1991) (59)
- The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction. (2000) (58)
- Rationale, Design, and Methods (1997) (58)
- Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis. (2004) (56)
- Localization of the central antinociceptive effects of diclofenac in the rat (1992) (56)
- Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP‐Hypertension‐2 (2004) (56)
- Serum leptin and myocardial infarction in hypertension (2004) (56)
- Central respiratory stimulant effect by thyrotropin in releasing hormone in the rat (1981) (55)
- The Nordic Diltiazem Study (NORDIL). A prospective intervention trial of calcium antagonist therapy in hypertension. (1993) (55)
- The Growth Hormone Secretagogue Hexarelin Improves Cardiac Function in Rats after Experimental Myocardial Infarction1. (2000) (54)
- Outcomes of epidural morphine treatment in cancer pain: nine years of clinical experience. (1995) (54)
- Effect of blood volume expansion and sympathetic denervation on plasma levels of atrial natriuretic factor (ANF) in the rat. (1985) (53)
- Characteristics, clinical effect profile and tolerability of a nasal spray preparation of Artemisia abrotanum L. for allergic rhinitis. (2004) (52)
- Importance of dietary salt in the hemodynamic adjustment to weight reduction in obese hypertensive men. (1984) (52)
- Nitric oxide in the oxygenator sweep gas reduces platelet activation during experimental perfusion. (1996) (52)
- Developmental variations in CSF monoamine metabolites during childhood. (1986) (51)
- Antepartum administration of terbutaline and the incidence of hyaline membrane disease in preterm infants (1978) (51)
- Intraarticular morphine after arthroscopic ACL reconstruction: A double-blind placebo-controlled study of 40 patients (2000) (51)
- Isolated systolic hypertension: an important cardiovascular risk factor. (1998) (49)
- Diabetes mellitus and raised serum triglyceride concentration in treated hypertension—are they of prognostic importance? Observational study (1996) (49)
- Effect of hypoxia on monoamine synthesis in brains of developing rats. (1977) (47)
- Opioids and opioid receptors in peripheral tissues. (1987) (47)
- Renal interaction between sympathetic activity and ANP in rats with chronic ischaemic heart failure. (1989) (47)
- An analysis of the mechanism by which gamma-aminobutyric acid depresses ventilation in the rat. (1984) (46)
- Hyperhomocysteinaemia is not associated with increased levels of asymmetric dimethylarginine in patients with ischaemic heart disease (2003) (46)
- Increased plasma levels of atrial natriuretic peptide in patients with congestive heart failure. (1986) (45)
- The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension (1999) (45)
- Benzodiazepine amplification of valproate teratogenic effects in children of mothers with absence epilepsy. (1993) (45)
- Characteristics of renal sympathetic nerve activity in experimental congestive heart failure in the rat. (1994) (45)
- Postoperative pain relief by topical lidocaine in the surgical wound of hysterectomized patients (1996) (45)
- Water intoxication associated with non-steroidal anti-inflammatory drug therapy. (2009) (44)
- Association between the low activity genotype of catechol-O-methyltransferase and myocardial infarction in a hypertensive population. (2004) (44)
- CSF and plasma concentrations of morphine and morphine glucuronides in cancer patients receiving epidural morphine (1993) (44)
- Concentrations of morphine and morphine metabolites in CSF and plasma during continuous subcutaneous morphine administration in cancer pain patients (1996) (43)
- Interaction of substance P with the respiratory control system in the rat. (1984) (43)
- Evidence for a dopamine interaction with the central respiratory control system in the rat. (1982) (42)
- Postoperative analgesic effects of intra-articular bupivacaine and morphine after arthroscopic cruciate ligament surgery (2005) (41)
- Transfer of terbutaline across the human placenta in late pregnancy. (1985) (41)
- Postoperative analgesic effects of an external cooling system and intra-articular bupivacaine/morphine after arthroscopic cruciate ligament surgery (2005) (40)
- Dose-responsive antihypertensive efficacy of valsartan, a new angiotensin II-receptor blocker. (1998) (40)
- Local application of somatostatin in the rat ventrolateral brain medulla induces apnea. (1990) (39)
- beta-Casomorphins induce apnea and irregular breathing in adult rats and newborn rabbits. (1987) (39)
- Cardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure. (1994) (39)
- Central, naloxone-reversible antinociception by diclofenac in the rat (1990) (39)
- Antagonistic effects of somatostatin and substance P on respiratory regulation in the rat ventrolateral medulla oblongata (1991) (39)
- Blunted renal sodium excretion during acute saline loading in normotensive men with positive family histories of hypertension. (1991) (39)
- The diuretic effect of atrial natriuretic peptide (ANP) is dependent on dopaminergic activation. (1986) (38)
- Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination. (2001) (37)
- Internetization Management as a Facilitator for Managing Innovation in High-Technology Smaller Firms (2013) (37)
- Characterization of the antinociceptive effects of some adenosine analogues in the rat (1986) (37)
- The SPRINT study: Outcome may be driven by difference in diuretic treatment demasking heart failure and study design may support systolic blood pressure target below 140 mmHg rather than below 120 mmHg (2016) (36)
- Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study (2002) (36)
- Evidence suggesting a role for substance P in central respiratory regulation in the rat. (1981) (36)
- Substance P in the ventrolateral medulla oblongata regulates ventilatory responses. (1990) (36)
- The J-curve phenomenon revisited again: SPRINT outcomes favor target systolic blood pressure below 120 mmHg (2016) (36)
- Mechanism of action of ketanserin in hypertension (1986) (35)
- CSF and plasma morphine concentrations in cancer patients during chronic epidural morphine therapy and its relation to pain relief (1987) (35)
- Atrial peptides, ANP(1-98) and ANP(99-126) in health and disease in an elderly population. (1993) (34)
- Acute volume expansion as a physiological stimulus for the release of atrial natriuretic peptides in the rat. (1986) (34)
- Haemodynamic effects and pharmacokinetics of oral d-and l-nebivolol in hypertensive patients (1996) (34)
- Short-term effects of felodipine, a new dihydropyridine, in hypertension. (1984) (33)
- Acute effects of short-term fasting on blood pressure, circulating noradrenaline and efferent sympathetic nerve activity. (2009) (33)
- The Swedish Trial in old patients with hypertension-2 (STOP-hypertension-2): a progress report. (1996) (33)
- Regional changes in monoamine synthesis in the developing rat brain during hypoxia. (1979) (33)
- Effect of coffee on ambulatory blood pressure in patients with treated hypertension (1993) (32)
- After SHEP, STOP and MRC--new WHO/ISH guidelines for the management of mild hypertension. (1993) (32)
- D-myo-inositol-1,2,6-trisphosphate is a selective antagonist of neuropeptide Y-induced pressor responses in the pithed rat. (1991) (32)
- Effects of atrial natriuretic peptide on renal function after cardiac surgery and in cyclosporine-treated heart transplant recipients. (1994) (32)
- Systolic and diastolic component of orthostatic hypotension and cardiovascular events in hypertensive patients: the Captopril Prevention Project (2014) (32)
- Increased levels of endothelin-1 in bronchoalveolar lavage fluid of patients with lung allografts. (1996) (31)
- The Captopril Prevention Project (CAPPP) in hypertension--baseline data and current status. (1997) (31)
- Atrial natriuretic peptides predict mortality in the elderly (1997) (31)
- Association analysis of the polymorphism T1128C in the signal peptide of neuropeptide Y in a Swedish hypertensive population (2004) (31)
- Similar cardiovascular effects of growth hormone and insulin-like growth factor-I in rats after experimental myocardial infarction. (2001) (31)
- Central haemodynamics, baroreceptor sensitivity and alpha 1-adrenoceptor-mediated vascular reactivity during weight-stable sodium restriction in obese men with hypertension. (1986) (31)
- Decision‐Making in the Pharmaceutical Industry: Analysis of Entrepreneurial Risk and Attitude Using Uncertain Information (2011) (30)
- Substance P-induced respiratory excitation is blunted by delta-receptor specific opioids in the rat medulla oblongata. (1996) (30)
- Renal and hemodynamic effects of isradipine in essential hypertension. (1989) (30)
- 2013 European Society of Hypertension/European Society of Cardiology Hypertension Guidelines (2013) (30)
- Grapefruit juice: a possible source of variability in blood concentration of cyclosporin A. (1993) (30)
- Enhanced pressor responses to experimental and daily‐life stress in borderline hypertension (1995) (30)
- Common Polymorphisms in the CYP11B1 and CYP11B2 Genes: Evidence for a Digenic Influence on Hypertension (2013) (29)
- Effects of d-myo-inositol-1,2,6-trisphosphate on neuropeptide Y-induced potentiation of various vasoconstrictor agents in the rat. (1992) (29)
- Airway effects of direct left-sided cervical vagal stimulation in patients with complex partial seizures (1994) (29)
- GABA concentrations and turnover in neonatal rat brain during asphyxia and recovery. (1983) (28)
- Increased plasma levels of atrial natriuretic peptide (ANP) in patients with paroxysmal supraventricular tachyarrhythmias. (2009) (28)
- Endothelium-derived relaxing factor (EDRF) and nitric oxide (NO). I. Physiology, pharmacology and pathophysiological implications. (1990) (28)
- A non-conservative polymorphism in the IL-6 signal transducer (IL6ST)/gp130 is associated with myocardial infarction in a hypertensive population (2008) (27)
- Felodipine--a new vasodilator, in addition to beta-receptor blockade in hypertension. (1983) (27)
- Neuropeptide Y potentiates noradrenaline-induced contraction through the neuropeptide Y Y1 receptor. (1996) (27)
- Plasma Atrial Natriuretic Peptide (Anp) And Maternal Hemodynamic Changes During Normal Pregnancy (1988) (27)
- Yohimbine pharmacokinetics and interaction with the sympathetic nervous system in normal volunteers (2005) (26)
- A comparison of metoprolol and morphine in the treatment of chest pain in patients with suspected acute myocardial infarction – the MEMO study (1999) (26)
- Haplotype association analysis of the polymorphisms Arg16Gly and Gln27Glu of the adrenergic β2 receptor in a Swedish hypertensive population (2005) (26)
- The Effect Duration of Candesartan Cilexetil Once Daily, in Comparison with Enalapril Once Daily, in Patients with Mild to Moderate Hypertension (2001) (25)
- Influence of intraperitoneal anesthesia on pain and the sympathoadrenal response to abdominal surgery (1988) (24)
- Organization structure theories and open innovation paradigm (2012) (24)
- The 1999 WHO-ISH Guidelines for the Management of Hypertension--new targets, new treatment and a comprehensive approach to total cardiovascular risk reduction. (1999) (24)
- Felodipine. A calcium-inhibiting vasodilator in refractory hypertension. (1985) (24)
- Platelet Function and Fibrinolytic Activity in Hypertension: Differential Effects of Calcium Antagonists and β‐Adrenergic Receptor Blockers (1991) (24)
- Neurochemical characteristics of cerebral catecholamine neurons during the postnatal development in the rat. (1981) (23)
- Alcohol and hypertension--how are they linked? (1999) (23)
- CSF neuropeptides in cancer pain: effects of spinal opioid therapy (1993) (23)
- Comparative Cardiovascular Effects of the Angiotensin II Type 1 Receptor Antagonists ZD 7155 and Losartan in the Rat (1996) (23)
- Innovation and entrepreneurship - new themes for new times (2010) (23)
- Flavonoids in grapefruit juice inhibit the in vitro hepatic metabolism of 17β-estradiol (1995) (23)
- Cardiovascular and renal effects of gamma-MSH in spontaneously hypertensive and normotensive Wistar Kyoto rats. (1992) (23)
- A comparative and long-term evaluation of ketanserin in the treatment of essential hypertension. (1985) (22)
- Neuropeptide Y in sympathetic co-transmission: recent advances in the search for neuropeptide Y antagonists (1994) (22)
- Catecholamine Concentration in the Developing Rat Brain after γ‐Hydroxybutyric Acid (1980) (22)
- Editorial: Recent hypertension guidelines: JNC-7 and 2003 ESH/ESC (2003) (22)
- Blood pressure and coronary heart disease. (1999) (22)
- Congestive heart failure induces downregulation of P2X1-receptors in resistance arteries. (1999) (22)
- Effect of hypoxia on monoamine synthesis in brains of developing rats. III. Various O2 levels. (1978) (22)
- Development of dopamine autoreceptors in the postnatal rat brain (2005) (21)
- Felodipine in hypertension--a review. (1987) (21)
- Catecholamine metabolism in neonatal rat brain during asphyxia and recovery. (1980) (21)
- Nonsteroidal antiinflammatory drug modulation of behavioral responses to intrathecal N-methyl-D-aspartate, but not to substance P and amino-methyl-isoxazole-propionic acid in the rat. (1996) (21)
- Pharmacokinetics of epidural morphine in man (2004) (21)
- Resting and volume-stimulated circulating atrial natriuretic peptide in young normotensive men with positive family histories of hypertension. (1991) (21)
- Central GABA mechanisms during postnatal development in the rat: Neurochemical characteristics (2005) (21)
- Enhanced Risk of Thromboembolic Disease in Hypertension from Platelet Hyperfunction and Decreased Fibrinolytic Activity: Has Antihypertensive Therapy Any Influence? (1992) (21)
- Felodipine — A new vasodilator, in addition to β-receptor blockade in hypertension (2004) (20)
- Blood Platelet Activation and Membrane Glycoprotein Changes during Extracorporeal Life Support (Ecls). In Vitro Studies (1995) (20)
- Radioimmunoassay of endothelin in human plasma. (1992) (20)
- Precipitation of angioedema by antihypertensive drugs. (1991) (20)
- Smoking and obesity associated BDNF gene variance predicts total and cardiovascular mortality in smokers (2013) (20)
- Pentane-1,5-diol as a percutaneous absorption enhancer (2005) (20)
- Decreased responsiveness of vascular postjunctional α1‐, α2‐adrenoceptors and neuropeptide Y1 receptors in rats with heart failure (1999) (20)
- Pressure-Volume Relationship and Fluid Content in Fetal Rabbit Lung after β-Receptor-Stimulating Drugs (1980) (19)
- Serotonin metabolism in neonatal rat brain during asphyxia and recovery. (1980) (19)
- CDKN2B expression and subcutaneous adipose tissue expandability: Possible influence of the 9p21 atherosclerosis locus (2014) (19)
- Antihypertensive effects of ketanserin in the spontaneously hypertensive rat: mode of action. (1985) (19)
- Effects of GABA and some GABA analogues on respiratory regulation in the preterm rabbit. (1983) (19)
- Anesthesiology Pharmacokinetic aspects of epidural morphine analgesia Anesthesiology, 58 (1983) 545–551 (1983) (19)
- State of global health – hypertension burden and control (2012) (19)
- Effects of taurine and a taurine antagonist on some respiratory and cardiovascular parameters. (1983) (19)
- Reactivity to norepinephrine and effect of sodium on blood pressure during weight loss. (1985) (19)
- Vascular alpha-2 adrenoceptor function is decreased in rats with congestive heart failure. (1996) (19)
- Hypersensitivity of Gi protein mediated muscarinic receptor adenylyl cyclase in chronic ischaemic heart failure in the rat. (1993) (18)
- Pharmacogenetic implications for eight common blood pressure-associated single-nucleotide polymorphisms (2012) (18)
- Ketanserin in essential hypertension: Effects during rest and exercise (2004) (18)
- Systemic and Renal Hemodynamic Effects of Single Oral Doses of Felodipine in Patients with Refractory Hypertension Receiving Chronic Therapy with β-Blockers and Diuretics (1985) (18)
- Effects of theophylline on adenosine-induced respiratory depression in the preterm rabbit. (1984) (18)
- Calcium antagonism in essential hypertension: effect on renal haemodynamics and microalbuminuria (1992) (18)
- Effects of antihypertensive therapy on glucose tolerance: focus on calcium antagonists. (1991) (18)
- Brain biochemical and behavioral changes in 4 weeks old rats after neonatal oxygen deprivation (1979) (18)
- Relationship between renal sympathetic activity and diuretic effects of atrial natriuretic peptide (ANP) in the rat. (1989) (17)
- Endothelium‐derived relaxing factor (EDRF) and nitric oxide (NO). II. (1990) (17)
- Cerebral and Adrenal Monoamine Metabolism in the Growth-Retarded Rat Fetus under Normoxia and Hypoxia (1992) (17)
- In vitro activity of artemisia abrotanum extracts against Malassezia Spp., Candida albicans and Staphylococcus aureus. (2007) (17)
- Characterization of neuropeptide Y receptors mediating contraction, potentiation and inhibition of relaxation. (1996) (17)
- Central monoamine metabolism and neonatal oxygen deprivation. An experimental study in the rat brain. (1978) (17)
- Blood pressure and intra-erythrocyte sodium during normal and high salt intake in middle-aged men: relationship to family history of hypertension, and neurogenic and hormonal variables. (1984) (17)
- gamma-Aminobutyric acid concentrations in the cerebrospinal fluid of newborn infants. (1982) (17)
- ANP--a cardiac hormone and a putative central neurotransmitter. (1987) (17)
- The in vitro activity of pentane-1,5-diol against aerobic bacteria. A new antimicrobial agent for topical usage? (2005) (16)
- Ketanserin in combination with beta-adrenergic receptor blocking agents in the treatment of essential hypertension. (1984) (16)
- Does Antihypertensive Therapy Affect the Natural Protection Against Thrombosis? (1991) (16)
- Inhibition of endothelin (ET-1) induced pressor responses by the endothelin (ETA) receptor antagonist FR139317 in the pithed rat. (1992) (16)
- A centrally elicited respiratory stimulant effect by bombesin in the rat. (1985) (16)
- Does Alcohol Absorb to Activated Charcoal? (1986) (16)
- Weight-reducing diets: role of carbohydrates on sympathetic nervous activity and hypotensive response. (1984) (16)
- Measures of endothelial function as an endpoint in hypertension? (1997) (15)
- Predictors for high costs of hospital care in elderly hypertensive patients (2006) (15)
- Antihypertensive mechanism of action of ketanserin and some ketanserin analogues in the spontaneously hypertensive rat (1985) (15)
- Change in the Pharmaceutical Industry : Aspects on Innovation, Entrepreneurship, Openness, and Decision Making (2012) (15)
- Characterization of adenosine-induced respiratory depression in the preterm rabbit. (1985) (15)
- Hypoventilation and apnoea induced by the substance P antagonist [D-Pro2,D-Trp7,9]-SP in the ventrolateral rat medulla. (1988) (14)
- The Early-Onset Myocardial Infarction Associated PHACTR1 Gene Regulates Skeletal and Cardiac Alpha-Actin Gene Expression (2015) (14)
- Serotoninergic development in the postnatal rat brain (2005) (14)
- Cardiovascular effects in the Sprague‐Dawley rat of 8−hydroxy−2(di‐ N‐propylamino) tetralin, a selective 5−hydroxytryptamine receptor agonist (1985) (14)
- Dilatory responses to acetylcholine, calcitonin gene-related peptide and substance P in the congestive heart failure rat. (1999) (14)
- Effects of clonidine on renal sympathetic nerve activity, natriuresis and diuresis in chronic congestive heart failure rats. (1992) (14)
- CSF and plasma pharmacokinetics of intramuscular morphine (2004) (14)
- Progress report on the Nordic diltiazem study (NORDIL): an outcome study in hypertensive patients. (1999) (14)
- Transient apnea after an enkephalin analogue in the preterm rabbit. (1981) (14)
- Morphine use and pharmacokinetics in patients with chest pain due to suspected or definite acute myocardial infarction (1998) (14)
- Respiratory stimulant effects by TRH into the mesencephalic region in the rat. (1987) (14)
- Hypertension and cardiovascular disease in women: Progress towards better understanding of gender‐specific differences? (2006) (14)
- Modulation of vascular contractile responses to α1-and α2-adrenergic and neuropeptide Y receptor stimulation in rats with ischaemic heart failure (1995) (14)
- Acute administration of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), a selective 5-HT-receptor agonist, causes a biphasic blood pressure response and a bradycardia in the normotensive Sprague-Dawley rat and in the spontaneously hypertensive rat (2005) (14)
- Increase in plasma atrial natriuretic peptides during acute volume expansion in hypertensive man. (2009) (14)
- GABA-ergic mechanisms in central respiratory control in the anesthetized rat (2004) (14)
- Blood pressure reduction and pharmacokinetics of ketanserin in hypertensive patients. (1986) (13)
- Chronic 5-HT2 receptor blockade with ritanserin does not reduce blood pressure in the spontaneously hypertensive rat (2005) (13)
- Changes in cerebrospinal fluid homovanillic acid in children with Ondine's curse (1987) (13)
- Changes in plasma atrial natriuretic peptide — immunoreactivity in patients undergoing coronary artery bypass graft placements (1987) (13)
- Experience with ketanserin, a serotonin (S2) antagonist, in longterm treatment of essential hypertension. (1984) (13)
- Haemodynamics and plasma ANP (atrial natriuretic peptide) after acute blood volume expansion in normotensive and spontaneously hypertensive rats. (1988) (13)
- Effects of chronic salt loading on plasma atrial natriuretic peptide (ANP) in the spontaneously hypertensive rat. (1987) (13)
- Homocysteine and ADMA--emerging risk factors for cardiovascular disease? (2002) (13)
- Atrial natriuretic peptide and catecholamines in peripheral blood as indicators of cardiac dysfunction in the general population. (1988) (13)
- Treatment of atopic dermatitis with 1% hydrocortisone and 25% pentane-1,5-diol: effect on Staphylococcus aureus. (2006) (13)
- Fetal hemolytic anemia associated with maternal sulfasalazine therapy during pregnancy (2006) (13)
- Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans (Nature Genetics (2008) 40, (189-197)) (2008) (12)
- The effect of α-trinositol (d-myo-Inositol 1,2,6-trisphosphate) on formalin-evoked spinal amino acid and prostaglandin E2 levels (1997) (12)
- Antihypertensive effects and pharmacokinetics of felodipine combined with a beta-blocker and a diuretic. (1987) (12)
- Effects of terbutaline on the pressure volume relationship in fetal rabbit lung (1978) (12)
- Haemodynamic, metabolic and endocrine effects of short-term dexfenfluramine treatment in young, obese women (2004) (12)
- Respiratory Effects of TRH in Preterm Rabbits (1982) (12)
- Effects of a new serotonin antagonist, ketanserin, in experimental and clinical hypertension. (1988) (12)
- Cerebrospinal fluid concentrations of neurotensin and corticotropin-releasing factor in pediatric patients. (1989) (12)
- Risk factor Identification and Assessment in Hypertension and Diabetes (RIAHD) study (2006) (12)
- The effects of alpha-trinositol on haemodynamic variables and neuropeptide Y levels in a pilot study of hypertensives and healthy volunteers. (1994) (12)
- Magnesium sulphate infusion decreases circulating calcitonin gene-related peptide (CGRP) in women with primary Raynaud's phenomenon. (1994) (12)
- Glucose tolerance in hypertensive patients during treatment with the calcium antagonist, felodipine. (1987) (11)
- Experience with ketanserin and ritanserin in hypertensive patients. (1988) (11)
- Treatment of essential hypertension with felodipine in combination with a diuretic (2004) (11)
- H29: Comparison of the efficacy of two angiotensin II antagonists, valsartan and losartan, in essential hypertension (1997) (11)
- Chronic 5-HT2-receptor blockade by ritanserin does not reduce blood pressure in patients with essential hypertension. (2009) (11)
- Respiratory depression by GABA-ergic drugs in the preterm rabbit. (1980) (11)
- Adrenal catecholamines during and following hypoxia in neonatal rats. (1980) (11)
- Management of hypertension: the advent of a new angiotensin II receptor antagonist. (1999) (11)
- Extradural morphine: influence of adrenaline admixture. (1986) (10)
- Pharmacokinetics of ketanserin in patients with essential hypertension (2004) (10)
- Effect of gammahydroxybutyric acid on serotonin synthesis, concentration and metabolism in the developing rat brain (2005) (10)
- α‐Trinositol: A Functional (Non‐receptor) Neuropeptide Y Antagonist in Vasculature (1996) (10)
- Antihypertensive effects of ketanserin and ritanserin in the spontaneously hypertensive rat. (1988) (10)
- Hypertension and Genetic Variation in Endothelial-Specific Genes (2013) (10)
- Cardiac conduction with diltiazem and beta-blockade combined. A review and report on cases. (1996) (10)
- Plasma atrial natriuretic peptide and haemodynamics in conscious normotensive and spontaneously hypertensive rats after acute blood volume expansion. (1985) (10)
- Cost analysis of different pharmacological treatment strategies in elderly hypertensives (2005) (10)
- The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension. The Eprosartan Multinational Study Group. (1999) (10)
- Health economy of the metabolic syndrome pandemic (2005) (10)
- Terbutaline and pulmonary surfactant release in the rabbit fetus. (1982) (9)
- Atrial natriuretic peptide during acute treatment of congestive heart failure. (1988) (9)
- Genome-wide association analysis identifies six new loci associated with blood low-density lipoprotein cholesterol , high-density lipoprotein cholesterol , or triglycerides in humans (2008) (9)
- The J-curve phenomenon revisited (2009) (9)
- Antinociceptive effect of alpha-trinositol, a novel D-myo-inositol phosphate derivative, in the formalin test in rats. (1995) (9)
- Diltiazem compared with metoprolol as add-on-therapies to diuretics in hypertension. Swedish Diltiazem-Metoprolol Multicentre Study Group. (1991) (9)
- Blood Pressure Measurement: A Century of Achievements and Improvements in the Year 2002 (2002) (9)
- Rapid Variations in Plasma Atrial Natriuretic Peptide (ANP) During Cardiopulmonary Bypass Surgery (1986) (9)
- Acute ischemic chest pain is not associated with increased calcitonin gene-related peptide (CGRP) levels in peripheral plasma nor in the coronary circulation. (1999) (9)
- Action of topical thyroid hormone analogues on glucocorticoid-induced skin atrophy in mice. (2006) (9)
- Physician and patient evaluation of hypertension-related risks and benefits from treatment. (1997) (9)
- Endothelin may be pathogenic in systemic sclerosis of the heart. (1997) (8)
- Effect of gammahydroxybutyric acid on catecholamine synthesis and utilization in the developing rat brain (2005) (8)
- Peptides as targets for antihypertensive drug development. (1992) (8)
- Blood pressure control and haemodynamic adaptation with the dihydropyridine calcium antagonist isradipine: a controlled study in middle-aged hypertensive men. (1989) (8)
- COVID-19—a very visible pandemic (2020) (8)
- Long Term Experience of Felodipine in Combination with β-Blockade and Diuretics in Refractory Hypertension (2012) (8)
- Cardiovascular responses and interactions by neuropeptide Y in rats with congestive heart failure. (1996) (8)
- Acute and long-term antihypertensive effect of bopindolol once daily or once weekly. (1986) (8)
- Antihypertensive Effects of Felodipine Compared with Placebo (2012) (8)
- Effects of diltiazem and metoprolol on blood pressure, adverse symptoms and general well-being (2004) (8)
- Effects and pharmacokinetics of high dose metoprolol on chest pain in patients with suspected or definite acute myocardial infarction (1997) (8)
- Comparative Effects of Verapamil and Volume Overload on Atrial Natriuretic Factors and the Renin‐Angiotensin Aldosterone‐Vasopressin System (1992) (8)
- The Diltiazem Different Doses Study--a dose-response study of once-daily diltiazem therapy for hypertension. (1996) (8)
- On the role of atrial natriuretic peptide in cardiovascular regulation in the spontaneously hypertensive rat. (1986) (8)
- Cardiovascular effects of alpha-trinositol in spontaneously hypertensive and normotensive Wistar-Kyoto rats (1993) (7)
- Renal denervation in treatment-resistant hypertension – Oslo RDN, Symplicity HTN-3 and INSPiRED randomized trials (2014) (7)
- Atrial natriuretic peptide attenuates pacing-induced myocardial ischemia during general anesthesia in patients with coronary artery disease. (1999) (7)
- The Problem of Hypertension in the Elderly (2000) (7)
- Neuropeptide Y-induced pressor responses in spontaneously hypertensive and Wistar-Kyoto rats antagonized by D-myo-inositol-1,2,6-triphosphate (PP56). (1991) (7)
- A comparison of diltiazem and metoprolol in hypertension (2004) (7)
- Acute and long-term antihypertensive effect of bopindolol – A nonselective β-adrenergic blocker with ISA (2004) (7)
- Capsaicin and regulation of respiration: Interaction with central substance P mechanisms (2005) (7)
- What is happening to blood pressure? (1996) (7)
- Effects of hydralazine on renal sympathetic nerve activity in normal and congestive heart failure rats. (1997) (7)
- Hypertension control – A global challenge (2005) (7)
- Increased erythrocyte sodium efflux during overfeeding without evidence of mediation by circulating catecholamines or thyroid hormone. (1984) (7)
- Comparative bioavailability of a cisapride suppository and tablet formulation in healthy volunteers (2004) (7)
- Blood pressure lowering effect of renal sympathetic denervation or placebo? - building expectations for Symplicity-HTN 3 (2013) (7)
- Modulation of vascular contractile responses to alpha 1- and alpha 2-adrenergic and neuropeptide Y receptor stimulation in rats with ischaemic heart failure. (1995) (7)
- Cardiovascular and renal effects of alpha-trinositol in ischemic heart failure rats. (1995) (7)
- Downregulation of adenosine and P2X receptor-mediated cardiovascular responses in heart failure rats. (2000) (7)
- Plasma Atrial Natriuretic Peptide (ANP) in Patients with Mild to Moderate Essential Hypertension (1986) (7)
- Hypertension and dementia: can antihypertensive treatment preserve cognitive function? (1999) (7)
- Antihypertensive effects of chronic 5-hydroxytryptamine (5-HT2) receptor blockade with ketanserin in the spontaneously hypertensive rat (1984) (7)
- Chronic serotonergic blockade with ketanserin in the spontaneously hypertensive rat. (1985) (7)
- Using scenario planning in regional development context: the challenges and opportunities (2013) (7)
- HOPE-3, SPRINT, VALUE and a meta-analysis of trials in patients with diabetes support treatment of hypertension to a target below 140 mmHg (2016) (7)
- WDR12, a Member of Nucleolar PeBoW-Complex, Is Up-Regulated in Failing Hearts and Causes Deterioration of Cardiac Function (2015) (7)
- Myocardial Circulatory and Metabolic Effects of Atrial Natriuretic Peptide After Coronary Artery Bypass Grafting (1996) (7)
- Cardiovascular Effects of Ketanserin During Cold Pressure and During Isometric and Dynamic Exercise in Hypertensive Patients (1987) (7)
- An American TROPHY in the prevention of hypertension (2006) (6)
- Effect of terbutaline on lung mechanics and morphology in the preterm rabbit neonate. (1983) (6)
- Renal and Cardiovascular Role of the Neuropeptide Y Y1 Receptor in Ischaemic Heart Failure Rats (1999) (6)
- The clinical profile of the angiotensin II receptor blocker eprosartan. (2002) (6)
- Sympathetic activation after two weeks of nifedipine treatment in primary Raynaud's patients and controls (1993) (6)
- RAAS inhibition – a practice of medical progress (2006) (6)
- Prevention of cardiovascular disease in uncomplicated, mild hypertension – need for prospective data from intervention trials (2004) (6)
- The changing structure of the pharmaceutical industry: perceptions on entrepreneurship and openness (2011) (6)
- A utilitarian or deontological approach toward primary prevention of cardiovascular disease? (2009) (6)
- A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertension (2005) (6)
- Comparison of Home and Office Blood Pressure in Treated Hypertensives in the Nordic Diltiazem (NORDIL) Study (2002) (6)
- Antihypertensive properties of ketanserin in combination with beta-adrenergic blocking agents. (1985) (6)
- Treatment of arterial hypertension with ketanserin in mono‐ and combination therapy (1985) (6)
- Entrepreneurial patent management in pharmaceutical startups. (2016) (6)
- Gammahydroxybutyric acid: Central biochemical and behavioral effects in neonatal rats (1985) (6)
- Angiotensin receptor - neprilysin inhibiton (ARNI) – A novel therapeutic concept for management of hypertension and heart failure (2012) (6)
- Significant relationship between renin suppression and atrial natriuretic peptide (alpha-hANP) during volume loading in hypertensive men. (2009) (6)
- Effects of 1,1-dimethylguanidine administration on blood pressure, heart rate and renal sympathetic nerve activity in normotensive and spontaneously hypertensive rats. (1997) (5)
- Is hypertension a risk factor for cancer? (1997) (5)
- Atrial Natriuretic Peptide in Healthy Children from Birth to Adolescence and in Children with Cardiac Diseases (1986) (5)
- Opioid Receptors: Types, Distribution, and Pharmacological Profiles (1990) (5)
- Effects of cold pressor test on circulating atrial natriuretic peptide 99-126 (ANP) in patients with Raynaud's phenomenon and influence of treatment with magnesium sulphate and nifedipine. (1993) (5)
- CSF and plasma pharmacokinetics of pethidine and norpethidine in man after epidural and intrathecal administration of pethidine (2004) (5)
- Raised plasma concentrations of endothelin-1 and -3 in marmosets with acute aortic stenosis: no relation to the renin-angiotensin system. (1992) (5)
- Haemodynamic adjustment to weight reduction--separate effects of energy versus salt restriction. (1983) (5)
- Should we treat prehypertension? (2009) (5)
- Central respiratory and cardiovascular effects in the rat of some putative neurotransmitter amino acids (1983) (5)
- Regional haemodynamics and antihypertensive effects during long-term ketanserin treatment. (1986) (5)
- ATRIAL NATRIURETIC FACTOR (ANF) IN PLASMA OF PATIENTS UNDERGOING CARDIOPULMONARY BYPASS SURGERY (1986) (5)
- Blood pressure and migration (2010) (5)
- Are there reasons to believe that the antihypertensive effects of serotonin (S2) antagonists are age-related? (1988) (5)
- Atrial natriuretic peptide (ANP) in relation to blood pressure: a study in middle‐aged men with normal and elevated blood pressure (1989) (5)
- Effects of Some Novel D-myo-Inositol‐Phosphate Derivatives on Binding and Sympathetic Transmission (1995) (5)
- The price you pay for hypertension management: incorporation of economic factors into clinical decision making (2002) (5)
- Ethnobotanical use of Southernwood, Artemisia abrotanum L. in Europe. (2002) (4)
- Lisinopril reduces postexercise albuminuria more effectively than atenolol in primary hypertension (2004) (4)
- Masked hypertension – a new entity and challenge for clinical hypertension research and management (2003) (4)
- Decreased responsiveness of vascular postjunctional alpha1-, alpha2-adrenoceptors and neuropeptide Y1 receptors in rats with heart failure. (1999) (4)
- Treating hypertension--effect of treatment and cost-effectiveness in respect to later cardiovascular diseases. (1998) (4)
- Evidence for a spinal antinociceptive effect of adenosine in the rat (1984) (4)
- Adrenaline in allergic emergencies: Authors' reply (1992) (4)
- Acute and long-term changes in plasma levels of atrial natriuretic factor in patients with renal replacement therapy (1990) (4)
- Renal nerve ablation: Emerging role in therapeutics (2011) (4)
- Implementing the SIV Model on an Intensively Innovation-Oriented Firm: The Case of Autoadapt AB (2012) (4)
- Beta‐blockers as sub‐optimal treatment for hypertension: Time for first‐line therapy revision? (2006) (4)
- Effect of terbutaline on lecithin content in alveolar lung wash in fetal rabbits. (1979) (4)
- A stunning day in hypertension research – Results of ONTARGET, ACCOMPLISH and HYVET (2008) (4)
- Enhanced Ca2+ ‐induced contractions and attenuated α‐adrenoceptor responses in resistance arteries from rats with congestive heart failure (2001) (4)
- Release of atrial natriuretic peptide (alpha-hANP) and circulating noradrenaline in relation to central and renal hemodynamics and sodium output during acute volume load in hypertensive and normotensive men. (2009) (4)
- EDITORIALHypertension and cardiovascular disease: Is arterial stiffness the heart of the matter? (2007) (4)
- Guanfacine in essential hypertension: Effects during rest and isometric exercise (1984) (4)
- The renin-angiotensin system--a century of progress. (1998) (4)
- D57 Results of a 13-week, double-blind, placebo-controlled study of the efficacy and safety of eprosartan in patients with essential hypertension (1997) (4)
- Functional explanation for increased atrial natriuretic peptide in systemic sclerosis (1995) (4)
- CDKN 2 B expression and subcutaneous adipose tissue expandability : Possible influence of the 9 p 21 atherosclerosis locus (2014) (4)
- Effects of Calcium Antagonist Felodipine on Renal Sympathetic Nerve Activity in Rats with Congestive Heart Failure (1997) (3)
- 5-HIAA levels in brain and cerebrospinal fluid of the neonatal rat during oxygen deprivation (1980) (3)
- Dissociation of renin and noradrenaline release in the renal circulation. Studies on patients with renal hypertension. (1986) (3)
- Perception of Risk through Phases of Drug Research and Development: Questionnaire Survey (2009) (3)
- Break-through for calcium antagonists in the treatment of hypertension based on the Syst-Eur results. (1998) (3)
- The enigmatic association of birth weight with blood pressure. (1997) (3)
- Fluid homeostasis and haemodynamics during sodium restriction in hypertensive men. (1985) (3)
- Magnesium sulphate increases plasma noradrenaline and neuropeptide-Y-like immunoreactivity (1995) (3)
- Scenario Planning as a Tool to Promote Innovation in Regional Development Context (2011) (3)
- Monoamine Synthesis and Concentration in Neonatal Rat Brain During Hypercapnia and Recovery (1982) (3)
- Effect of hypoxia on monoamine synthesis in brains of developing rats. II. Different length of exposure. (1977) (3)
- Endothelium-derived relaxing factor (EDRF) and nitric oxide (NO). II. Physiology, pharmacology and pathophysiological implications. (1990) (3)
- Comparison of Antihypertensive Effect and Pharmacokinetics of Conventional and Extended Release Felodipine Tablets in Patients with Arterial Hypertension (2012) (3)
- The growing importance of systolic blood pressure. (1998) (3)
- Antihypertensive effects of chronic 5-hydroxytryptamine (5-HT2) receptor blockade with irindalone in the spontaneously hypertensive rat (2005) (3)
- Urgent need to address quality control issues of out‐of‐office blood pressure measurement and patient risk assessment (2008) (3)
- EDITORIAL The growing importance of systolic blood pressure (1998) (3)
- Plasma noradrenaline and neuropeptide-Y may not be of primary importance in the pathophysiology of cardiac involvement in systemic sclerosis. (1999) (3)
- The polypill: an emerging treatment alternative for secondary prevention of cardiovascular disease (2016) (3)
- Hypertension and coronary artery disease: Mechanistic insights and therapeutic challenges (2005) (3)
- Managing Innovation in a Globalised Economy : Defining the Open Capital (2009) (3)
- Age-dependent effects of beta 2-adrenergic-stimulating drugs on fetal rabbit lung liquid and adrenal catecholamines. (1988) (3)
- Cardiovascular complications of COX2 selective inhibitors cause considerable concern (2004) (3)
- POSSIBLE INVOLVEMENT OE γ- AMINOBUTYRIC ACID (GABA) AND ENKEPHALINE IN TRANSIENT APNOEA AND RESPIRATORY DEPRESSION IN PRETERM RABBITS (1981) (3)
- Effects of sodium restriction and energy reduction on erythrocyte sodium transport in obese hypertensive men. (1988) (3)
- Gamma-melanocyte-stimulating hormones have pressor and natriuretic effects in spontaneously hypertensive and Wistar-Kyoto rats. (1991) (3)
- Histamine-independent modulation of the neuropeptide Y-induced pressor response by alpha-trinositol in the pithed rat. (1994) (3)
- The Rationale for Ketanserin Therapy in Hypertension (1987) (3)
- Hypertension research into the new millennium (2010) (3)
- Hypertension Management by Practice Guidelines (2014) (3)
- [Is antihypertensive treatment a risk factor of coronary disease? Therapy-related triglyceride increase nor diabetes increase the risk]. (1998) (3)
- Psychosocial factors and blood pressure. Why are nuns better off? (1997) (3)
- The problem of hypertension in the elderly. (2000) (3)
- The impact of open IP platforms on IP-strategy norms in Life Sciences (2012) (3)
- Central sympathoinhibitory effect of ketanserin in the spontaneously hypertensive rat. (1989) (3)
- Pharmacokinetics of different epidural sites of morphine administration (2004) (2)
- Angiotensin receptor blockers and cancer – Relationship dismissed by VALUE data while waiting for EMA and FDA reports (2010) (2)
- Congestive heart failure induces downregulation of P2X -receptors in 1 resistance arteries (1999) (2)
- Atrial natriuretic peptide and its relation to cardiac dimensions and function in patients with systemic sclerosis. (1994) (2)
- Central, naloxone-reversible antinocicepeion by diciofenae in the rat (1990) (2)
- Plasma atrial natriuretic peptide and blood pressure during chronic salt loading in spontaneously hypertensive rats with right atrial appendectomy (2005) (2)
- On Salt and Treatment Goals in Hypertension: Time for Reappraisal? (1992) (2)
- Business and Technology Incubators and their Role in the Nordic Countries in Comparison to the GCC countries: An Analysis of Current Affairs (2011) (2)
- Acute systemic and renal haemodynamic effects and long-term antihypertensive action of cadralazine in patients pretreated with β-blockers and diuretics (2004) (2)
- Nitric oxide and blood pressure in normotensive patients on chronic hemodialysis. (1998) (2)
- Differential haemodynamic effects of atrial natriuretic peptide (ANP) in normotensive and spontaneously hypertensive rats. (1988) (2)
- Acute and long‐term changes in plasma levels of atrial natriuretic factor in patients with renal replacement therapy (1990) (2)
- Endothelial Dysfunction - A Challenge for Hypertension Research (2000) (2)
- Atrial natriuretic peptide: relation to left ventricular filling properties in patients with systemic sclerosis. (1994) (2)
- Antihypertensive therapy and cancer risks? (2011) (2)
- Improved glucocorticoid replacement therapy by a novel oral hydrocortisone modified-release tablet (2007) (2)
- Achieving better blood pressure control (2008) (2)
- Serotonin-induced platelet aggregation predicts the antihypertensive response to serotonin receptor antagonists (2004) (2)
- 2,2′‐Nitrophenylisatogen potentiates P2X1 receptor mediated vascular contraction and blood pressure elevation (2003) (2)
- Contrasting Messages but not Contradicting Results from ALLHAT and ANBP2 (2003) (2)
- Dose-dependent effects of verapamil and nifedipine on in vivo platelet function in normal volunteers (2004) (2)
- ONTARGET, TRANSCEND and PROFESS – Clarifying, confusing or misleading (2009) (2)
- The Lower the Better - PROGRESS of the Concept (2001) (2)
- Chapter 8 – Neuropeptide Y Receptor Subtypes and Putative Receptor Ligands (1993) (2)
- Catecholamine concentration in the developing rat brain after gamma-hydroxybutyric acid. (1980) (2)
- Angiotensin receptor blockers and endpoint protection (2005) (2)
- Blood pressure control – Slowly getting there through new strategies? (2007) (2)
- The Captopril Prevention Project, Further Analyses on Left Ventricular Hypertrophy and Diabetes (2001) (2)
- Risk reduction when treating hypertension--are there differences between the various classes of drugs? (1995) (2)
- The evolution of ACE inhibition – A turning point in cardiovascular medicine (2007) (2)
- Open Innovation in the Biomedical Sector - An Alternative Approach to Organizational Value Extraction (2011) (2)
- Blood pressure variability: Emerging role in risk assessment and therapeutics (2010) (2)
- ENHANCED BLOOD PRESSURE LOWERING EFFECT IN HYPERTENSIVE PATIENTS ON COMBINED SILDENAFIL AND LERCANIDIPINE TREATMENT: P3.52 (2000) (2)
- CHARACTERISTICS OF REVERSED OFFICE HYPERTENSION - MAY TREATMENT RESISTANT HOME HYPERTENSION BE EXPLAINED BY SMOKING?: 4A.5 (2004) (1)
- Failure of randomisation by “sealed” envelope (1999) (1)
- Post-registration studies for the evaluation of antihypertensive drugs (2011) (1)
- Clinical Evaluation of Felodipine in Hypertensive Patients Previously Treated with a Triple Drug Regimen (2012) (1)
- Plasma Levels of Atrial Natriuretic Peptide (ANP) in SHR During Acute and Chronic Salt Loading (1986) (1)
- Antihypertensive and metabolic effects of bopindolol at rest and during exercise – is once weekly dosage possible? (1988) (1)
- Substance P influences basal ventilation and ventilatory reflexes in the ventrolateral medulla oblongata of the rat (1988) (1)
- Cost‐effectiveness of blood pressure measurement and hypertension follow‐up (2006) (1)
- An appropriate SCORE to assess cardiovascular risk in hypertension? (2011) (1)
- Medical decision making in hypertension (2006) (1)
- There is a need for more aggressive implementation of combination strategies to control hypertensive risk (2007) (1)
- Microcalorimetric study of myocardial tissue metabolism in heart failure after experimental myocardial infarction in rats (1996) (1)
- VALSARTAN PROVIDES EFFECTIVE ANTIHYPERTENSIVE RESPONSE IN OLDER PATIENTS: AN INTEGRATED ANALYSIS (2000) (1)
- Can Innovation Enhance Entrepreneurial Activities of a Region? An Analysis Utilizing the Entrepreneurial Remedy Model (EREM) (2011) (1)
- Clonidine influences renal sympathetic nerve activity and renal function in experimental heart failure. (1991) (1)
- Obstructive sleep apnea and hypertension--double trouble? (1993) (1)
- A016: Ambulatory blood pressure assessment of once-daily candesartan cilexetil versus enalapril in patients with hypertension (2000) (1)
- Survival of neonatal rats during hypoxia after monoamine stimulating agents. (2009) (1)
- Awareness, management and follow-up of lipoprotein disturbances in hypertension. (1999) (1)
- EFFECTS OF ANGIOTENSIN II ANTAGONISTS ON SYMPATHETIC NERVE ACTIVITY IN CHF RATS. A COMPARISON BETWEEN EPROSARTAN AND LOSARTAN: 1C.2 (2000) (1)
- 1A.10: ASSOCIATION BETWEEN GENE POLYMORPHISMS AND RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY HEART DISEASE (2015) (1)
- Systemic and renal hemodynamic effects of single oral doses of cadralazine and long term antihypertensive effects of cadralazine in patients receiving therapy with beta-blockers and diuretics. (2009) (1)
- Pharmacokinetic evaluation of oral 17β-oestradiol and two different fat soluble analogues in ovariectomized women (2006) (1)
- Prediction of insulin resistance. (1996) (1)
- The Renal Dopamine System Mediates the Diuretic/Natriuretic Effect of Atrial Natriuretic Peptide (1986) (1)
- The Parathyroid Hypertensive Factor: Important Evidence Is Accumulating (1993) (1)
- Management of hypertension – more focus on treatment targets (2003) (1)
- Altered neuropeptide Y Y1 responses in mesenteric arteries in rats with congestive heart failure. (1998) (1)
- Muirhead's syndrome--a syndrome of medullipin dependent hypotension. (1992) (1)
- BOOK REVIEWS: Hypertension as an insulin‐resistant disorder (1993) (1)
- Does it take guts to prevent hypertension? (1995) (1)
- ACE Inhibitor as One of Several Possible First-Line Agents Is Reasonable for Diabetic Patients With Hypertension (2002) (1)
- SMOKING AND OBESITY ASSOCIATED BDNF GENE VARIANCE PREDICTS TOTAL AND CARDIOVASCULAR MORTALITY IN SMOKERS (THE CARENORTH CONSORTIUM): 9D.07 (2011) (1)
- Endothelial dysfunction--a challenge for hypertension research. (2000) (1)
- Emerging Open Models and Concepts of Innovation in the Pharmaceutical Sector (2011) (1)
- Effects of antenatal hydrocortisone on tidal volumes in spontaneously breathing preterm newborn rabbits. Possible mediation by adrenal catecholamines. (1988) (1)
- Physiological antagonism between somatostatin and substance P on respiratory regulation in the ventrolateral medulla oblongara of the rat (1988) (1)
- The parathyroid hypertensive factor--facts and future. (1994) (1)
- More is Less? Optimal Combination Therapy for Adequate Blood Pressure Lowering in Hypertension (2008) (1)
- [Proposals on the innovation policy by Ostros--correct diagnosis but wrong treatment]. (2004) (0)
- [The Swedish Society of Hypertension: cooperation with industry is desirable and necessary--with integrity preserved]. (2003) (0)
- POTENTIAL HAZARDS OF BENZODIAZEPINES FOR THE FOETUS (1992) (0)
- Effects of atrial natriuretic factor on renal function after cardiac surgery and heart transplantation (1994) (0)
- A pharmaceutical composition for the treatment of acute pain by sublingual administration, use of fentanyl or a pharmaceutically acceptable salt thereof, and use of a pharmaceutical composition substantially free of water. (1999) (0)
- A remarkable remedy receives Nobel Prize recognition. (1999) (0)
- Revisiting the pre-hypertension debate: Increasing evidence for treatment – or not? (2013) (0)
- Blood pressure @ Internet-www.bloodpressure.nu [editorial] (2000) (0)
- In vivo effects and release mechanisms of atrial natriuretic peptide in experimental animals (1986) (0)
- The surge of Japanese studies supporting the use of angiotensin receptor blockers in hypertension (2009) (0)
- Primary cardiovascular prevention by Mediterranean diet – The PREDIMED trial (2013) (0)
- More focus on therapeutic targets and improved tolerability in hypertension (2008) (0)
- Postmenopausal Hormone Replacement Therapy and Hypertension (2000) (0)
- In light of ALLHAT and ASCOT: Are there benefits of statins as add-on treatment in hypertensives? (2003) (0)
- Hemodynamic and humoral adaptation to weight stable chronic sodium restriction in comparison with weight reduction in moderately obese hypertensive men. (2009) (0)
- Prediction of insulin resistance [editorial; comment] (1996) (0)
- Does GISSI-AF change the concept of using RAS inhibitors in the primary prevention of atrial fibrillation in hypertensive patients? (2009) (0)
- [Major changes in the global pharmaceutical industry]. (2012) (0)
- Improved method for the determination of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine in tissue using high-performance liquid chromatography with electrochemical detection. (1992) (0)
- Cardiovascular effects of irindalone, a new S2-serotonergic antagonist, in the rat. (1990) (0)
- OLD AND NEW ANTIHYPERTENSIVE TREATMENT OF ELDELY HYPERTENSIVES WITH SYSTOLIC HYPERTENSION – A SUBANALYSIS OF STOP-HYPERTENSION-2: P2.48 (2000) (0)
- Growth hormone and insulin-like growth factor I improve cardiac function and regulate expression of the Fas receptor in rats after experimental myocardial infarction (1998) (0)
- Effects of adrenaline admixture to epidural morphine (1984) (0)
- Ambulatory Blood Pressure Adds to Explaining Benefits of AT‐1 Receptor Blockade in the Treatment of Left Ventricular Hypertrophy (2007) (0)
- The growth hormone secretagogue hexarelinimproves cardiac function in rats following experimental myocardial infarction (1999) (0)
- Compositions having effect against allergic symptoms and process for its preparation (2001) (0)
- G025: Valsartan provides effective antihypertensive response in African-Americans: An integrated analysis (2000) (0)
- Functional polymorphism of the NEDD4L gene strongly influences cardiovascular outcome in hypertensive patients treated with beta-blockers and diuretics (2008) (0)
- Left ventricular hypertrophy--should it be looked for in all hypertensive patients? (1996) (0)
- Endothelin in hypertension--a matter ignored or to be ignored? (1994) (0)
- Fentamil composition for the treatment of acute pain (1999) (0)
- symptoms preparations for the treatment of allergic and their manufacturing processes (2001) (0)
- Topical composition enhanced (2002) (0)
- Researchers Receive Record Compensation from TV Company for Media Insult Linked to the Calcium Antagonist Controversy (2002) (0)
- Use of lactic acid oligomers in the treatment of gynecological infections (2008) (0)
- PHARMACEUTICAL COMPOSITIONS FOR ACUTE glucocorticoid (2005) (0)
- Blood pressure--then and now. (1996) (0)
- 205 Cardiovascular effects of endothelin-1 and the endothelin-A receptor antagonist FR 139317 in the pithed rat (1993) (0)
- EXPERIENCE WITH KETANSERIN, A SEBXCNIN (S ) (1984) (0)
- THE EFFECT DURATION OF CANDESARTAN AND ENALAPRIL ON AMBULATORY BLOOD PRESSURE IN PATIENTS WITH HYPERTENSION USING A FORCED TITRATION STUDY DESIGN: P3.222 (2000) (0)
- Hypertension research in the United Kingdom and Ireland--a source of inspiration. (1996) (0)
- Editorial: Prediction of insulin resistance (1996) (0)
- Association between an estrogen receptor alpha polymorphism (ERA : rs2234693) and the metabolic syndrome and cardiovascular and cerebrovascular morbidity and mortality (2008) (0)
- Antihypertensive therapy--a viable branch of medicine [editorial] (1997) (0)
- Blood pressure--then and now [editorial] (1996) (0)
- Direct renin inhibitors in hypertension – Approaching the moment of truth (2012) (0)
- G020: Valsartan provides effective antihypertensive response in older patients: An integrated analysis (2000) (0)
- FAILURE OF RANDOMISATION BY SEALED ENVELOPE. AUTHORS' REPLY (1999) (0)
- Peter Meredith (2016) (0)
- [There is no reason to avoid calcium antagonists in hypertension]. (1996) (0)
- [ACE inhibitors and pregnancy]. (1992) (0)
- Treatment of high blood pressure in acute stroke – The SCAST Study (2011) (0)
- Use of a product comprising absorption 1,5-pentanediol as deodorant (2006) (0)
- PP.LB03.02: SINGLE NUCLEOTIDE POLYMORPHISMS CONTRIBUTES TO LEFT VENTRICULAR DIASTOLIC FUNCTION IN HYPERTENSIVE SUBJECTS (2015) (0)
- [Endogenous opioids in the central nervous system]. (1981) (0)
- The Art of Prediction and Prevention (1994) (0)
- Renal hypertensive target organ damage – new evidence emerges in diabetics and smokers (2004) (0)
- PRINCIPAL RESULTS OF THE NORDIL HYPERTENSION TRIAL – A COMPARISON BETWEEN DILTIAZEM AND DIURETIC/BETABLOCKER BASED TREATMENT: P2.46 (2000) (0)
- CSF AND plasma morphine concentrations during chronic epidural therapy (1987) (0)
- Increased time varying heart rate and cardiovascular risk in hypertension – Benefit of selective I(f) channel inhibitor? (2012) (0)
- EXPRESSION OF THE CARDIOVASCULAR SUSCEPTIBILITY GENE CDKN2B IS UP REGULATED IN OBESITY AND ASSOCIATES WITH FACTORS OF THE METABOLIC SYNDROME: 1D.02 (2011) (0)
- Contents, Vol. 47, 1985 (1985) (0)
- Blood Pressure celebrates 20 years of dedication to Nordic hypertension research (2010) (0)
- Lennart Hansson 1940-2002 Chief Editor of BLOOD PRESSURE (2002) (0)
- Nabumetone Use and Safety Profile in the Management of Osteoarthritis and Rheumatoid Arthritis (2004) (0)
- Composition topique potentialisee (2002) (0)
- Smoking affects blood pressure [editorial] (1996) (0)
- Impact of Uncertainty on Drug Development Decision Making in the Pharmaceutical Industry (2012) (0)
- Critical aspects in hypertension diagnosis and treatment (2009) (0)
- PP.06.39: GENETIC RISK SCORES AND VASCULAR STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION (2015) (0)
- Felodipine in Combination with a β-Blocker and a Diuretic in Chronic Treatment of Patients with Refractory Primary Hypertension (2012) (0)
- Felodipine (2020) (0)
- New ESH Hypertension Excellence centers approved (2008) (0)
- Obituary – Björn Folkow (2012) (0)
- The dram locus at 12Q23 is associated with grade 2 hypertension (2009) (0)
- New Editor (2005) (0)
- Cardiovascular risk stratification: an important tool for treatment to lower cardiovascular disease risk (2004) (0)
- The Blood Pressure 10th Anniversary Research Prize (2002) (0)
- Hypertension management in practice--priorities and problems. (1998) (0)
- Blood Pressure Risks and Awards (1995) (0)
- ASCOT – More than a horse race! (2005) (0)
- [Atrial natriuretic factor--a new bioactive peptide from cardiac atria]. (1985) (0)
- Cardiovascular consequences and management of high-normal blood pressure – more work needs to be done (2001) (0)
- Assessment of Risks of Hypertension and Benefits of Treatment - a Difficult Matter (2000) (0)
- Valuable lessons from VALUE (2004) (0)
- The Effect of A100 Gel, on Hair Growth and Hair Quality: An Explanatory Study (2016) (0)
- [Cooperation with colleagues from the Baltic states is important]. (1994) (0)
- The human cardiac transplant recipient--a "living laboratory" for studies of cardiac neurophysiology. (1993) (0)
- Blood Pressure Measurement - Bringing It All Back Home (2000) (0)
- The kidney in hypertension--culprit or innocent bystander? (1994) (0)
- Effects of sympathetic inhibition in rats with chronic ischemic heart failure resistant to ANP (1990) (0)
- Analysis of a Swedish High Technology SME Using the Survival Index Value (SIV) Model (2011) (0)
- [Combination drugs in the treatment of hypertension. Simpler for patients, physicians and pharmacies]. (1995) (0)
- A population study ofthepharmacokinetics offelodipine (1991) (0)
- [Reflections on COX, Vioxx and Relifex. Increased cardiovascular risk following selective COX-2 inhibition]. (2004) (0)
- Combination treatment in hypertension – the latest 2013 European Guidelines (2013) (0)
- Chapter 17 – Perivascular Peptides (NPY, CGRP, and SP) in Hypertension and Congestive Heart Failure (1993) (0)
- Calcium antagonists--looking stronger by the day. (1997) (0)
- Second Life Environment a planning and project platform in Regional Development (2011) (0)
- Editorial: Hypertension Management in Practice - Priorities and Problems (1998) (0)
- Blood pressure and coronary heart disease [editorial; comment] (1999) (0)
- REDUCED CARDIOVASCULAR MORBIDITY AND MORTALITY IN DIABETIC HYPERTENSIVES WITH ACEI COMPARED TO DIURETIC/BETABLOCKER BASED TREATMENT – A SUBANALYSIS OF CAPPP: P2.47 (2000) (0)
- Book Review (2010) (0)
- Ten years of BLOOD PRESSURE—Looking back and forward (2001) (0)
- Blood pressure @ Internet-www.bloodpressure.nu. (2000) (0)
- DEVELOPMENT OF DIABETES IN CAPPP – A COMPARISON BETWEEN ACEI AND DIURETIC/BETABLOCKER BASED TREATMENT: P2.42 (2000) (0)
- Clinical pharmacokinetics and safety of fentanyl following sublingual administration of a rapidly dissolving tablet in cancer patients: a new approach for treating incident pain (2003) (0)
- Measuring blood pressure in children and adolescents. (1998) (0)
- Fentanylzusammensetzung for treatment of acute pain (1999) (0)
- Unsatisfactory blood pressure control--patient's neglect or doctor's hesitation? (1997) (0)
- [Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness]. (2012) (0)
- Benefits of hypertension management in diabetes: An opportunity not to be missed (2008) (0)
- THE SWEDISH ESTONIAN LONG-TERM EVALUATION OF CARDIOVASCULAR RISK TRENDS [SELECT[ PROJECT – INITIAL RESULTS: P3.107 (2000) (0)
- The hypertension optimal treatment (hot) study — Home BP in treated hypertensives (1997) (0)
- CAPPP trial (1999) (0)
- AFRICAN-AMERICANS: AN INTEGRATED ANALYSIS (2000) (0)
- Beta 2-adrenergic treatment of neonatal hypoxic disorders. (1981) (0)
- Composition of fentanil for the treatment of acute pain. (1999) (0)
- Documentation of endpoint prevention with combination therapy in hypertension is urgently needed (2007) (0)
- Ambulatory blood pressure--defining normalcy of a very variable variable. (1995) (0)
- High mortality explained by mildly elevated blood pressure in Scandinavian adolescent conscripts – A plea for early drug treatment? (2011) (0)
- [Swedish research needs Swedish innovation. The research and innovation strategy must strengthen Swedish competitiveness]. (2013) (0)
- Substance-P and somatostatin spinal fluid content in patients with cancer pain. Influence of 1spinal opiatle therapy (1990) (0)
- The question of whether diabetes and its cardiovascular risks can be prevented: A realistic DREAM? (2006) (0)
- Editorial: Blood Pressure—Then and Now (1996) (0)
- Novel aspects of therapeutics in Blood Pressure: Drug Therapy Supplements (2003) (0)
- Sverre E. Kjeldsen joins the Editorial Office of Blood Pressure (2003) (0)
- The Bergen Blood Pressure Study revisited. (1995) (0)
- Management of coexisting risk factors in hypertension--safe and sound? (1995) (0)
- [Ambulatory blood pressure measurement--guidelines for registration and data processing]. (1991) (0)
- Management of older hypertensive patients (2008) (0)
- Blunted renal effects of atrial natriuretic peptide in rats with chronic ischemic heart failure (1988) (0)
- Implementation of 24-hour Blood Pressure Control (2010) (0)
- I008: Valsartan is an effective antihypertensive in both women and men: An integrated analysis (2000) (0)
- Replacement of pharmaceutical compositions for therapy with glucocorticoids (2005) (0)
- Antihypertensive therapy--a viable branch of medicine. (1997) (0)
- 44 STOP-Hypertension 2 (1993) (0)
- Cardiovascular risks in HIV patients (2010) (0)
- The discovery of dopamine rewarded--the Nobel Prize in Physiology and Medicine 2000. (2001) (0)
- The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of cardiovascular risk factors and coronary events in patients with hypertension (2008) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Thomas Hedner,?
Thomas Hedner, is affiliated with the following schools:
